- /
- Supported exchanges
- / US
- / ETRA.NASDAQ
Electra Therapeutics, Inc. Common stock (ETRA NASDAQ) stock market data APIs
Electra Therapeutics, Inc. Common stock Financial Data Overview
Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer. Its lead product candidate is ipsoprubart, that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, treatment for secondary hemophagocytic lymphohistiocytosis and T/NK Cell Malignancies; ELA822, a novel SIRP-specific monoclonal antibody for deplete activated T cells, treatment for T cell mediated immune disorders. Electra Therapeutics, Inc. was incorporated in 2018 and is based in South San Francisco, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Electra Therapeutics, Inc. Common stock data using free add-ons & libraries
Get Electra Therapeutics, Inc. Common stock Fundamental Data
Electra Therapeutics, Inc. Common stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Electra Therapeutics, Inc. Common stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Electra Therapeutics, Inc. Common stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Electra Therapeutics, Inc. Common stock News
New
Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London
Electra Therapeutics SOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc. (NASDAQ: ETRA) a late clinical-stage biopharmaceutical company focused on pioneering a n...
Star Therapeutics Announces $200 Million Private Financing to Advance Pipeline of Best-in-Disease Therapies
Financing will support Star's next phase of growth, including advancement of current preclinical programs into the clinic and continued pipeline expansion Financing follows Incyte's July 2026 acquisi...
Catalyst watch: Big bank earnings, CPI, and the Paris Auto Show
[Finance background] honglouwawa Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock pric...
Oura Shows How Shaky the IPO Market Really Is
Oura is the fourth company to pull the plug on its stock offering this month. Higher bond yields are partly to blame. But the bigger culprit is that investors only have eyes for big AI IPOs like Anthropic. Continue Reading
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.